These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
688 related articles for article (PubMed ID: 23216887)
1. Seroprevalence of Toxoplasma gondii and associated risk factors among pregnant women in Jimma town, Southwestern Ethiopia. Zemene E; Yewhalaw D; Abera S; Belay T; Samuel A; Zeynudin A BMC Infect Dis; 2012 Dec; 12():337. PubMed ID: 23216887 [TBL] [Abstract][Full Text] [Related]
2. Seroprevalence and risk factors of Toxoplasma gondii infection in pregnant women following antenatal care at Mizan Aman General Hospital, Bench Maji Zone (BMZ), Ethiopia. Abamecha F; Awel H BMC Infect Dis; 2016 Sep; 16(1):460. PubMed ID: 27585863 [TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risk factors in women of child-bearing age in Njinikom, NW Cameroon. Wam EC; Sama LF; Ali IM; Ebile WA; Aghangu LA; Tume CB BMC Res Notes; 2016 Aug; 9(1):406. PubMed ID: 27528009 [TBL] [Abstract][Full Text] [Related]
4. Seroepidemiology of Toxoplasma gondii infection in women of child-bearing age in central Ethiopia. Gebremedhin EZ; Abebe AH; Tessema TS; Tullu KD; Medhin G; Vitale M; Di Marco V; Cox E; Dorny P BMC Infect Dis; 2013 Feb; 13():101. PubMed ID: 23442946 [TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of Toxoplasma gondii among pregnant women attending antenatal clinics at Hawassa University comprehensive specialized and Yirgalem General Hospitals, in Southern Ethiopia. Fenta DA BMC Infect Dis; 2019 Dec; 19(1):1056. PubMed ID: 31842783 [TBL] [Abstract][Full Text] [Related]
6. Serological survey and risk factors associated with Zakari MM; Isah AY; Offiong R; Yunusa T; Abdullahi IN Malawi Med J; 2020 Sep; 32(3):160-167. PubMed ID: 33488988 [TBL] [Abstract][Full Text] [Related]
7. Seroprevalence and risk factors of Toxoplasma gondii among pregnant women in Adwa district, northern Ethiopia. Teweldemedhin M; Gebremichael A; Geberkirstos G; Hadush H; Gebrewahid T; Asgedom SW; Gidey B; Asres N; Gebreyesus H BMC Infect Dis; 2019 Apr; 19(1):327. PubMed ID: 30991956 [TBL] [Abstract][Full Text] [Related]
8. Seroprevalence and risk factors of Toxoplasma gondii infection in pregnant women from Bobo Dioulasso, Burkina Faso. Bamba S; Cissé M; Sangaré I; Zida A; Ouattara S; Guiguemdé RT BMC Infect Dis; 2017 Jul; 17(1):482. PubMed ID: 28693432 [TBL] [Abstract][Full Text] [Related]
9. Seroprevalence and associated risk factors of Toxoplasma gondii among Manchu pregnant women in northeastern China. Jiang RL; Ma LH; Ma ZR; Hou G; Zhao Q; Wu X Microb Pathog; 2018 Oct; 123():398-401. PubMed ID: 30063975 [TBL] [Abstract][Full Text] [Related]
10. Toxoplasma gondii infection among pregnant women in Yemen: Factors associated with high seroprevalence. Al-Eryani SM; Al-Mekhlafi AM; Al-Shibani LA; Mahdy MM; Azazy AA J Infect Dev Ctries; 2016 Jun; 10(6):667-72. PubMed ID: 27367017 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and predictors of Toxoplasma gondii infection in pregnant women from Dhamar, Yemen. Al-Adhroey AH; Mehrass AAO; Al-Shammakh AA; Ali AD; Akabat MYM; Al-Mekhlafi HM BMC Infect Dis; 2019 Dec; 19(1):1089. PubMed ID: 31888517 [TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of toxoplasmosis and risk factors of Toxoplasma gondii infection among pregnant women in Sri Lanka: a cross sectional study. Iddawela D; Vithana SMP; Ratnayake C BMC Public Health; 2017 Dec; 17(1):930. PubMed ID: 29202747 [TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of Anti-Toxoplasma gondii Antibodies Among Lebanese Pregnant Women. Nahouli H; El Arnaout N; Chalhoub E; Anastadiadis E; El Hajj H Vector Borne Zoonotic Dis; 2017 Dec; 17(12):785-790. PubMed ID: 29064352 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of Toxoplasma gondii infection and associated risk factors among pregnant women in Debre Tabor, Northwest Ethiopia. Agmas B; Tesfaye R; Koye DN BMC Res Notes; 2015 Mar; 8():107. PubMed ID: 25879788 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the toxoplasmosis seroprevalence in pregnant women and creating a diagnostic algorithm]. Mumcuoglu I; Toyran A; Cetin F; Coskun FA; Baran I; Aksu N; Aksoy A Mikrobiyol Bul; 2014 Apr; 48(2):283-91. PubMed ID: 24819265 [TBL] [Abstract][Full Text] [Related]
16. Seropositivity of Toxoplasmosis in Pregnant Women by ELISA at Minia University Hospital, Egypt. Kamal AM; Ahmed AK; Abdellatif MZ; Tawfik M; Hassan EE Korean J Parasitol; 2015 Oct; 53(5):605-10. PubMed ID: 26537040 [TBL] [Abstract][Full Text] [Related]
17. Investigation of Seropositivity of Anti- Aksoy Sanay N; Mor N; Şahin D Turkiye Parazitol Derg; 2024 Oct; 48(3):164-170. PubMed ID: 39373591 [TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of Toxoplasma gondii and Associated Risk Factors among Pregnant Women in Algeria. Sebaa S; Behnke JM; Labed A; Abu-Madi MA Am J Trop Med Hyg; 2024 Jun; 110(6):1137-1144. PubMed ID: 38688274 [TBL] [Abstract][Full Text] [Related]
19. Awareness, knowledge and risk factors of Eroglu S; Asgin N J Obstet Gynaecol; 2021 Jul; 41(5):714-720. PubMed ID: 33045851 [No Abstract] [Full Text] [Related]
20. Seroprevalence, Seroconversion, and Risk Factors for Toxoplasmosis among Pregnant Women in Taipei, Taiwan. Hung CS; Su HW; Lee YL; Weng HW; Wang YC; Naito T; Tsubouchi A; Wang GC; Fan CK Jpn J Infect Dis; 2015; 68(4):312-7. PubMed ID: 25720644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]